Associated Papers
Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945.
Wang Y et al.
Npj Precision Oncology, 2025
40836025 (PubMed )
Supplement: 41698_2025_1086_MOESM1_ESM.pdf
Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment.
Beagan JJ et al.
Lung Cancer (amsterdam, Netherlands), 2020
Detection and benchmarking of somatic mutations in cancer genomes using RNA-seq data.
Coudray A et al.
Peerj, 2018
Select a paper to view details